- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Patients today have more treatment options in the battle against coronavirus disease.
In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.
The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.
The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.
In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.
In this report, we study all treatment method for Covid-19.
According to our latest study, the global Covid-19 Treatment market size was valued at USD 14310 million in 2022 and is forecast to a readjusted size of USD 41 million by 2029 with a CAGR of -56.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.
This report is a detailed and comprehensive analysis for global Covid-19 Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Covid-19 Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Covid-19 Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Covid-19 Treatment market size and forecasts, by Type and by End User, in consumption value ($ Million), 2018-2029
Global Covid-19 Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Covid-19 Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Covid-19 Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cadila Healthcare, Johnson & Johnson, ImmunoPrecise, Novartis and AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Covid-19 Treatment market is split by Type and by End User. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Life Support
Antiviral Medicine
Antibody Treatments
Others
Market segment by End User
Children
Adult
Market segment by players, this report covers
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
Sanofi
Pfizer
Eli Lilly
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Covid-19 Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Covid-19 Treatment, with revenue, gross margin and global market share of Covid-19 Treatment from 2018 to 2023.
Chapter 3, the Covid-19 Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Covid-19 Treatment market forecast, by regions, type and end user, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Covid-19 Treatment.
Chapter 13, to describe Covid-19 Treatment research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Covid-19 Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Covid-19 Treatment by Type
1.3.1 Overview: Global Covid-19 Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Covid-19 Treatment Consumption Value Market Share by Type in 2022
1.3.3 Life Support
1.3.4 Antiviral Medicine
1.3.5 Antibody Treatments
1.3.6 Others
1.4 Global Covid-19 Treatment Market by End User
1.4.1 Overview: Global Covid-19 Treatment Market Size by End User: 2018 Versus 2022 Versus 2029
1.4.2 Children
1.4.3 Adult
1.5 Global Covid-19 Treatment Market Size & Forecast
1.6 Global Covid-19 Treatment Market Size and Forecast by Region
1.6.1 Global Covid-19 Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Covid-19 Treatment Market Size by Region, (2018-2029)
1.6.3 North America Covid-19 Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe Covid-19 Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Covid-19 Treatment Market Size and Prospect (2018-2029)
1.6.6 South America Covid-19 Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Covid-19 Treatment Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Cadila Healthcare
2.1.1 Cadila Healthcare Details
2.1.2 Cadila Healthcare Major Business
2.1.3 Cadila Healthcare Covid-19 Treatment Product and Solutions
2.1.4 Cadila Healthcare Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Cadila Healthcare Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Covid-19 Treatment Product and Solutions
2.2.4 Johnson & Johnson Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 ImmunoPrecise
2.3.1 ImmunoPrecise Details
2.3.2 ImmunoPrecise Major Business
2.3.3 ImmunoPrecise Covid-19 Treatment Product and Solutions
2.3.4 ImmunoPrecise Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ImmunoPrecise Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Covid-19 Treatment Product and Solutions
2.4.4 Novartis Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments and Future Plans
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Covid-19 Treatment Product and Solutions
2.5.4 AstraZeneca Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments and Future Plans
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Covid-19 Treatment Product and Solutions
2.6.4 Cipla Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cipla Recent Developments and Future Plans
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business
2.7.3 AbbVie Covid-19 Treatment Product and Solutions
2.7.4 AbbVie Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AbbVie Recent Developments and Future Plans
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Covid-19 Treatment Product and Solutions
2.8.4 Bayer Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bayer Recent Developments and Future Plans
2.9 Regeneron Pharmaceuticals
2.9.1 Regeneron Pharmaceuticals Details
2.9.2 Regeneron Pharmaceuticals Major Business
2.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Product and Solutions
2.9.4 Regeneron Pharmaceuticals Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.10 Ascletis Pharma
2.10.1 Ascletis Pharma Details
2.10.2 Ascletis Pharma Major Business
2.10.3 Ascletis Pharma Covid-19 Treatment Product and Solutions
2.10.4 Ascletis Pharma Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ascletis Pharma Recent Developments and Future Plans
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Covid-19 Treatment Product and Solutions
2.11.4 GlaxoSmithKline Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 GlaxoSmithKline Recent Developments and Future Plans
2.12 Gilead Sciences
2.12.1 Gilead Sciences Details
2.12.2 Gilead Sciences Major Business
2.12.3 Gilead Sciences Covid-19 Treatment Product and Solutions
2.12.4 Gilead Sciences Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Gilead Sciences Recent Developments and Future Plans
2.13 Pharmstandard
2.13.1 Pharmstandard Details
2.13.2 Pharmstandard Major Business
2.13.3 Pharmstandard Covid-19 Treatment Product and Solutions
2.13.4 Pharmstandard Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Pharmstandard Recent Developments and Future Plans
2.14 Fujifilm Holdings
2.14.1 Fujifilm Holdings Details
2.14.2 Fujifilm Holdings Major Business
2.14.3 Fujifilm Holdings Covid-19 Treatment Product and Solutions
2.14.4 Fujifilm Holdings Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Fujifilm Holdings Recent Developments and Future Plans
2.15 Zhejiang Hisun Pharmaceutical Co. Ltd
2.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Details
2.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Major Business
2.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product and Solutions
2.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments and Future Plans
2.16 Roche
2.16.1 Roche Details
2.16.2 Roche Major Business
2.16.3 Roche Covid-19 Treatment Product and Solutions
2.16.4 Roche Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Roche Recent Developments and Future Plans
2.17 Sanofi
2.17.1 Sanofi Details
2.17.2 Sanofi Major Business
2.17.3 Sanofi Covid-19 Treatment Product and Solutions
2.17.4 Sanofi Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Sanofi Recent Developments and Future Plans
2.18 Pfizer
2.18.1 Pfizer Details
2.18.2 Pfizer Major Business
2.18.3 Pfizer Covid-19 Treatment Product and Solutions
2.18.4 Pfizer Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Pfizer Recent Developments and Future Plans
2.19 Eli Lilly
2.19.1 Eli Lilly Details
2.19.2 Eli Lilly Major Business
2.19.3 Eli Lilly Covid-19 Treatment Product and Solutions
2.19.4 Eli Lilly Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Eli Lilly Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Covid-19 Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Covid-19 Treatment by Company Revenue
3.2.2 Top 3 Covid-19 Treatment Players Market Share in 2022
3.2.3 Top 6 Covid-19 Treatment Players Market Share in 2022
3.3 Covid-19 Treatment Market: Overall Company Footprint Analysis
3.3.1 Covid-19 Treatment Market: Region Footprint
3.3.2 Covid-19 Treatment Market: Company Product Type Footprint
3.3.3 Covid-19 Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Covid-19 Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global Covid-19 Treatment Market Forecast by Type (2024-2029)
5 Market Size Segment by End User
5.1 Global Covid-19 Treatment Consumption Value Market Share by End User (2018-2023)
5.2 Global Covid-19 Treatment Market Forecast by End User (2024-2029)
6 North America
6.1 North America Covid-19 Treatment Consumption Value by Type (2018-2029)
6.2 North America Covid-19 Treatment Consumption Value by End User (2018-2029)
6.3 North America Covid-19 Treatment Market Size by Country
6.3.1 North America Covid-19 Treatment Consumption Value by Country (2018-2029)
6.3.2 United States Covid-19 Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada Covid-19 Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico Covid-19 Treatment Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Covid-19 Treatment Consumption Value by Type (2018-2029)
7.2 Europe Covid-19 Treatment Consumption Value by End User (2018-2029)
7.3 Europe Covid-19 Treatment Market Size by Country
7.3.1 Europe Covid-19 Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany Covid-19 Treatment Market Size and Forecast (2018-2029)
7.3.3 France Covid-19 Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Covid-19 Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia Covid-19 Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy Covid-19 Treatment Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Covid-19 Treatment Consumption Value by End User (2018-2029)
8.3 Asia-Pacific Covid-19 Treatment Market Size by Region
8.3.1 Asia-Pacific Covid-19 Treatment Consumption Value by Region (2018-2029)
8.3.2 China Covid-19 Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan Covid-19 Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea Covid-19 Treatment Market Size and Forecast (2018-2029)
8.3.5 India Covid-19 Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Covid-19 Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia Covid-19 Treatment Market Size and Forecast (2018-2029)
9 South America
9.1 South America Covid-19 Treatment Consumption Value by Type (2018-2029)
9.2 South America Covid-19 Treatment Consumption Value by End User (2018-2029)
9.3 South America Covid-19 Treatment Market Size by Country
9.3.1 South America Covid-19 Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil Covid-19 Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina Covid-19 Treatment Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Covid-19 Treatment Consumption Value by End User (2018-2029)
10.3 Middle East & Africa Covid-19 Treatment Market Size by Country
10.3.1 Middle East & Africa Covid-19 Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey Covid-19 Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Covid-19 Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE Covid-19 Treatment Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Covid-19 Treatment Market Drivers
11.2 Covid-19 Treatment Market Restraints
11.3 Covid-19 Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Covid-19 Treatment Industry Chain
12.2 Covid-19 Treatment Upstream Analysis
12.3 Covid-19 Treatment Midstream Analysis
12.4 Covid-19 Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Covid-19 Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Covid-19 Treatment Consumption Value by End User, (USD Million), 2018 & 2022 & 2029
Table 3. Global Covid-19 Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Covid-19 Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Cadila Healthcare Company Information, Head Office, and Major Competitors
Table 6. Cadila Healthcare Major Business
Table 7. Cadila Healthcare Covid-19 Treatment Product and Solutions
Table 8. Cadila Healthcare Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Cadila Healthcare Recent Developments and Future Plans
Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Covid-19 Treatment Product and Solutions
Table 13. Johnson & Johnson Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Johnson & Johnson Recent Developments and Future Plans
Table 15. ImmunoPrecise Company Information, Head Office, and Major Competitors
Table 16. ImmunoPrecise Major Business
Table 17. ImmunoPrecise Covid-19 Treatment Product and Solutions
Table 18. ImmunoPrecise Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. ImmunoPrecise Recent Developments and Future Plans
Table 20. Novartis Company Information, Head Office, and Major Competitors
Table 21. Novartis Major Business
Table 22. Novartis Covid-19 Treatment Product and Solutions
Table 23. Novartis Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Novartis Recent Developments and Future Plans
Table 25. AstraZeneca Company Information, Head Office, and Major Competitors
Table 26. AstraZeneca Major Business
Table 27. AstraZeneca Covid-19 Treatment Product and Solutions
Table 28. AstraZeneca Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. AstraZeneca Recent Developments and Future Plans
Table 30. Cipla Company Information, Head Office, and Major Competitors
Table 31. Cipla Major Business
Table 32. Cipla Covid-19 Treatment Product and Solutions
Table 33. Cipla Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Cipla Recent Developments and Future Plans
Table 35. AbbVie Company Information, Head Office, and Major Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Covid-19 Treatment Product and Solutions
Table 38. AbbVie Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. AbbVie Recent Developments and Future Plans
Table 40. Bayer Company Information, Head Office, and Major Competitors
Table 41. Bayer Major Business
Table 42. Bayer Covid-19 Treatment Product and Solutions
Table 43. Bayer Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Bayer Recent Developments and Future Plans
Table 45. Regeneron Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Regeneron Pharmaceuticals Major Business
Table 47. Regeneron Pharmaceuticals Covid-19 Treatment Product and Solutions
Table 48. Regeneron Pharmaceuticals Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Regeneron Pharmaceuticals Recent Developments and Future Plans
Table 50. Ascletis Pharma Company Information, Head Office, and Major Competitors
Table 51. Ascletis Pharma Major Business
Table 52. Ascletis Pharma Covid-19 Treatment Product and Solutions
Table 53. Ascletis Pharma Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Ascletis Pharma Recent Developments and Future Plans
Table 55. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 56. GlaxoSmithKline Major Business
Table 57. GlaxoSmithKline Covid-19 Treatment Product and Solutions
Table 58. GlaxoSmithKline Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. GlaxoSmithKline Recent Developments and Future Plans
Table 60. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 61. Gilead Sciences Major Business
Table 62. Gilead Sciences Covid-19 Treatment Product and Solutions
Table 63. Gilead Sciences Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Gilead Sciences Recent Developments and Future Plans
Table 65. Pharmstandard Company Information, Head Office, and Major Competitors
Table 66. Pharmstandard Major Business
Table 67. Pharmstandard Covid-19 Treatment Product and Solutions
Table 68. Pharmstandard Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Pharmstandard Recent Developments and Future Plans
Table 70. Fujifilm Holdings Company Information, Head Office, and Major Competitors
Table 71. Fujifilm Holdings Major Business
Table 72. Fujifilm Holdings Covid-19 Treatment Product and Solutions
Table 73. Fujifilm Holdings Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Fujifilm Holdings Recent Developments and Future Plans
Table 75. Zhejiang Hisun Pharmaceutical Co. Ltd Company Information, Head Office, and Major Competitors
Table 76. Zhejiang Hisun Pharmaceutical Co. Ltd Major Business
Table 77. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product and Solutions
Table 78. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments and Future Plans
Table 80. Roche Company Information, Head Office, and Major Competitors
Table 81. Roche Major Business
Table 82. Roche Covid-19 Treatment Product and Solutions
Table 83. Roche Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Roche Recent Developments and Future Plans
Table 85. Sanofi Company Information, Head Office, and Major Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi Covid-19 Treatment Product and Solutions
Table 88. Sanofi Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Recent Developments and Future Plans
Table 90. Pfizer Company Information, Head Office, and Major Competitors
Table 91. Pfizer Major Business
Table 92. Pfizer Covid-19 Treatment Product and Solutions
Table 93. Pfizer Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Pfizer Recent Developments and Future Plans
Table 95. Eli Lilly Company Information, Head Office, and Major Competitors
Table 96. Eli Lilly Major Business
Table 97. Eli Lilly Covid-19 Treatment Product and Solutions
Table 98. Eli Lilly Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Eli Lilly Recent Developments and Future Plans
Table 100. Global Covid-19 Treatment Revenue (USD Million) by Players (2018-2023)
Table 101. Global Covid-19 Treatment Revenue Share by Players (2018-2023)
Table 102. Breakdown of Covid-19 Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Covid-19 Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Covid-19 Treatment Players
Table 105. Covid-19 Treatment Market: Company Product Type Footprint
Table 106. Covid-19 Treatment Market: Company Product Application Footprint
Table 107. Covid-19 Treatment New Market Entrants and Barriers to Market Entry
Table 108. Covid-19 Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Covid-19 Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Covid-19 Treatment Consumption Value Share by Type (2018-2023)
Table 111. Global Covid-19 Treatment Consumption Value Forecast by Type (2024-2029)
Table 112. Global Covid-19 Treatment Consumption Value by End User (2018-2023)
Table 113. Global Covid-19 Treatment Consumption Value Forecast by End User (2024-2029)
Table 114. North America Covid-19 Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Covid-19 Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Covid-19 Treatment Consumption Value by End User (2018-2023) & (USD Million)
Table 117. North America Covid-19 Treatment Consumption Value by End User (2024-2029) & (USD Million)
Table 118. North America Covid-19 Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Covid-19 Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Covid-19 Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Covid-19 Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Covid-19 Treatment Consumption Value by End User (2018-2023) & (USD Million)
Table 123. Europe Covid-19 Treatment Consumption Value by End User (2024-2029) & (USD Million)
Table 124. Europe Covid-19 Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Covid-19 Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Covid-19 Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Covid-19 Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Covid-19 Treatment Consumption Value by End User (2018-2023) & (USD Million)
Table 129. Asia-Pacific Covid-19 Treatment Consumption Value by End User (2024-2029) & (USD Million)
Table 130. Asia-Pacific Covid-19 Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Covid-19 Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Covid-19 Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Covid-19 Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Covid-19 Treatment Consumption Value by End User (2018-2023) & (USD Million)
Table 135. South America Covid-19 Treatment Consumption Value by End User (2024-2029) & (USD Million)
Table 136. South America Covid-19 Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Covid-19 Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Covid-19 Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Covid-19 Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Covid-19 Treatment Consumption Value by End User (2018-2023) & (USD Million)
Table 141. Middle East & Africa Covid-19 Treatment Consumption Value by End User (2024-2029) & (USD Million)
Table 142. Middle East & Africa Covid-19 Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Covid-19 Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Covid-19 Treatment Raw Material
Table 145. Key Suppliers of Covid-19 Treatment Raw Materials
List of Figures
Figure 1. Covid-19 Treatment Picture
Figure 2. Global Covid-19 Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Covid-19 Treatment Consumption Value Market Share by Type in 2022
Figure 4. Life Support
Figure 5. Antiviral Medicine
Figure 6. Antibody Treatments
Figure 7. Others
Figure 8. Global Covid-19 Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Covid-19 Treatment Consumption Value Market Share by End User in 2022
Figure 10. Children Picture
Figure 11. Adult Picture
Figure 12. Global Covid-19 Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Covid-19 Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Covid-19 Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Covid-19 Treatment Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Covid-19 Treatment Consumption Value Market Share by Region in 2022
Figure 17. North America Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Covid-19 Treatment Revenue Share by Players in 2022
Figure 23. Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Covid-19 Treatment Market Share in 2022
Figure 25. Global Top 6 Players Covid-19 Treatment Market Share in 2022
Figure 26. Global Covid-19 Treatment Consumption Value Share by Type (2018-2023)
Figure 27. Global Covid-19 Treatment Market Share Forecast by Type (2024-2029)
Figure 28. Global Covid-19 Treatment Consumption Value Share by End User (2018-2023)
Figure 29. Global Covid-19 Treatment Market Share Forecast by End User (2024-2029)
Figure 30. North America Covid-19 Treatment Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Covid-19 Treatment Consumption Value Market Share by End User (2018-2029)
Figure 32. North America Covid-19 Treatment Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Covid-19 Treatment Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Covid-19 Treatment Consumption Value Market Share by End User (2018-2029)
Figure 38. Europe Covid-19 Treatment Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 40. France Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Covid-19 Treatment Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Covid-19 Treatment Consumption Value Market Share by End User (2018-2029)
Figure 46. Asia-Pacific Covid-19 Treatment Consumption Value Market Share by Region (2018-2029)
Figure 47. China Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 50. India Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Covid-19 Treatment Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Covid-19 Treatment Consumption Value Market Share by End User (2018-2029)
Figure 55. South America Covid-19 Treatment Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Covid-19 Treatment Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Covid-19 Treatment Consumption Value Market Share by End User (2018-2029)
Figure 60. Middle East and Africa Covid-19 Treatment Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
Figure 64. Covid-19 Treatment Market Drivers
Figure 65. Covid-19 Treatment Market Restraints
Figure 66. Covid-19 Treatment Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Covid-19 Treatment in 2022
Figure 69. Manufacturing Process Analysis of Covid-19 Treatment
Figure 70. Covid-19 Treatment Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
